# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Roper Technologies (NASDAQ: ROP) beat revenue and EPS estimates in Q1 2024, with a 14% Y/Y revenue growth and increased profits...
Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communic...
The Invesco Water Resources ETF (NASDAQ: PHO) is down approximately 21% year-to-date, compared to the S&P 500 which is down...
These are dry times. Droughts are becoming more common and are lasting longer. In the Western United States, for example, th...